201.
Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK
by Koyuturk, Meral
Cancer letters, 2006, Vol.250 (2), p.220-228
202.
Safety of High-Dose Atorvastatin Therapy
by Waters, David D
The American journal of cardiology, 2005, Vol.96 (5), p.69-75
203.
The endotoxin-lipoprotein hypothesis
by Rauchhaus, Mathias
The Lancet (British edition), 2000, Vol.356 (9233), p.930-933
204.
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage
by Kramer, Andreas H
Neurosurgery, 2008-02, Vol.62 (2), p.422-430
205.
OP-087 Short- And Long-Term Effect of Simvastatin Therapy on the Heterogeneity of Cardiac Repolarization in Diabetic Patients
by Tekin, Abdullah
The American journal of cardiology, 2016, Vol.117, p.S35-S35
206.
Modulation of Adhesion Molecules by Cholesterol‐Lowering Therapy in Mononuclear Cells from Hypercholesterolemic Patients
by Cerda, Alvaro
Cardiovascular therapeutics, 2015-08, Vol.33 (4), p.168-176
207.
Role of simvastatin in prevention of vasospasm and improving functional outcome after aneurysmal sub-arachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controll...
by Garg, K
British journal of neurosurgery, 2013-04, Vol.27 (2), p.181-186
208.
Effect of simvastatin on glioma cell proliferation, migration, and apoptosis
by Wu, Hongtao
Neurosurgery, 2009-12, Vol.65 (6), p.1087-1097
209.
Effect of Simvastatin on Hemostasis in Patients with Isolated Hypertriglyceridemia
by Krysiak, Robert
Pharmacology, 2013-11, Vol.92 (3-4), p.187-190
210.
Long-term (48-week) safety of ezetimibe 10 mg/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia
by Bays, Harold
Current medical research and opinion, 2008-10, Vol.24 (10), p.2953-2966
211.
New Fixed‐Dose Combinations of Fenofibrate/Simvastatin Therapy Significantly Improve the Lipid Profile of High‐Risk Patients with Mixed Dyslipidemia Versus Monotherapies
by Foucher, Christelle
Cardiovascular therapeutics, 2015-12, Vol.33 (6), p.329-337
212.
Clinical experience with ezetimibe/simvastatin in a Mediterranean population
by Migdalis, I
Current medical research and opinion, 2009-10, Vol.25 (10), p.2571-2576
213.
Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia
by Maki, Kevin C., PhD
The American journal of cardiology, 2008, Vol.102 (4), p.429-433
214.
Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study
by Mohiuddin, Syed M., MD
The American heart journal, 2009, Vol.157 (1), p.195-203
215.
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study
by Borghi, Claudio
The American heart journal, 2004, Vol.148 (2), p.285-292
216.
The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells
by Rodrigues, Alice Cristina
Acta pharmacologica Sinica, 2009, Vol.30 (7), p.956-964
217.
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study
by Group, Heart Protection Study Collaborative
The Lancet (British edition), 2011, Vol.377 (9764), p.469-476
218.
Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors
by Jacobson, Terry A
The American journal of cardiology, 2004, Vol.94 (9), p.1140-1146
219.
Simvastatin improves neutrophil migratory targeting in COPD: in vitro studies supporting statin use as a potential adjuvant therapy
by Sadhra, CS
Thorax, 2013-12-01, Vol.68 (12), p.A59
220.
Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial
by Becker, David J., MD
Mayo Clinic proceedings, 2008, Vol.83 (7), p.758-764
